Fortress Biotech Stock Buy Hold or Sell Recommendation
| FBIO Stock | USD 1.61 0.04 2.55% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Fortress Biotech is 'Strong Sell'. The recommendation algorithm takes into account all of Fortress Biotech's available fundamental, technical, and predictive indicators you will find on this site.
Check out Fortress Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide. In addition, we conduct extensive research on individual companies such as Fortress and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Fortress |
Execute Fortress Biotech Buy or Sell Advice
The Fortress recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Fortress Biotech. Macroaxis does not own or have any residual interests in Fortress Biotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Fortress Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Fortress Biotech Trading Alerts and Improvement Suggestions
| Fortress Biotech generated a negative expected return over the last 90 days | |
| Fortress Biotech may become a speculative penny stock | |
| Fortress Biotech has high historical volatility and very poor performance | |
| Fortress Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 84.51 M. Net Loss for the year was (60.64 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| Fortress Biotech currently holds about 208.35 M in cash with (128.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Fortress Biotech has a frail financial position based on the latest SEC disclosures | |
| Roughly 21.0% of the company shares are held by company insiders | |
| Latest headline from businesswire.com: Fortress Acquires Texas Hydraulics, Leading Hydraulic Solutions Company |
Fortress Biotech Returns Distribution Density
The distribution of Fortress Biotech's historical returns is an attempt to chart the uncertainty of Fortress Biotech's future price movements. The chart of the probability distribution of Fortress Biotech daily returns describes the distribution of returns around its average expected value. We use Fortress Biotech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Fortress Biotech returns is essential to provide solid investment advice for Fortress Biotech.
| Mean Return | -0.27 | Value At Risk | -5.08 | Potential Upside | 7.43 | Standard Deviation | 4.36 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Fortress Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Fortress Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Fortress Biotech, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Fortress Biotech back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-09-30 | 78.1 K | Atria Investments Llc | 2024-09-30 | 71.5 K | 180 Wealth Advisors, Llc | 2024-09-30 | 68.3 K | Meridian Wealth Management, Llc | 2024-06-30 | 65.5 K | Millennium Management Llc | 2024-06-30 | 65.2 K | Commonwealth Equity Services Inc | 2024-06-30 | 61.7 K | Hb Wealth Management, Llc | 2024-09-30 | 55.3 K | Northern Trust Corp | 2024-09-30 | 41.4 K | Titleist Asset Management, Llc | 2024-09-30 | 39 K | Vanguard Group Inc | 2024-09-30 | 625.1 K | Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 554.4 K |
Fortress Biotech Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 9.4M | 7.2M | 16.3M | 3.1M | 63K | 59.9K | |
| End Period Cash Flow | 153.4M | 235.0M | 308.0M | 181.0M | 83.4M | 116.5M | |
| Change In Cash | 71.9M | 81.6M | 73.0M | (127.0M) | (97.6M) | (92.7M) | |
| Free Cash Flow | (104.4M) | (90.8M) | (132.9M) | (182.5M) | (136.3M) | (129.5M) | |
| Depreciation | 4.7M | 5.3M | 6.8M | 9.4M | 6.0M | 3.0M | |
| Other Non Cash Items | 12.0M | 10.5M | 24.4M | 2.9M | (78.1M) | (74.2M) | |
| Net Income | (101.7M) | (103.0M) | (164.8M) | (213.9M) | (60.6M) | (63.7M) | |
| Change To Inventory | (179K) | (547K) | (8.5M) | 1.7M | 4.0M | 4.2M | |
| Dividends Paid | 2.3M | 2.6M | 6.8M | 8.8M | 8.8M | 4.9M | |
| Change To Netincome | (1.8M) | 13.3M | (43.3M) | 20.3M | 18.3M | 19.2M | |
| Investments | 17.6M | (7.2M) | 56.9M | (22.9M) | (2.4M) | (2.3M) | |
| Net Borrowings | 1K | 14.7M | (29.7M) | (15.0M) | (13.5M) | (12.9M) |
Fortress Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Fortress Biotech or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Fortress Biotech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Fortress stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.4 | |
β | Beta against Dow Jones | 1.23 | |
σ | Overall volatility | 4.38 | |
Ir | Information ratio | -0.09 |
Fortress Biotech Volatility Alert
Fortress Biotech exhibits very low volatility with skewness of -0.82 and kurtosis of 4.07. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Fortress Biotech's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Fortress Biotech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Fortress Biotech Fundamentals Vs Peers
Comparing Fortress Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Fortress Biotech's direct or indirect competition across all of the common fundamentals between Fortress Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Fortress Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Fortress Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Fortress Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Fortress Biotech to competition |
| Fundamentals | Fortress Biotech | Peer Average |
| Return On Equity | -17.4 | -0.31 |
| Return On Asset | -0.36 | -0.14 |
| Profit Margin | (0.49) % | (1.27) % |
| Operating Margin | (1.69) % | (5.51) % |
| Current Valuation | 56.02 M | 16.62 B |
| Shares Outstanding | 27.56 M | 571.82 M |
| Shares Owned By Insiders | 21.20 % | 10.09 % |
| Shares Owned By Institutions | 14.46 % | 39.21 % |
| Number Of Shares Shorted | 2.62 M | 4.71 M |
| Price To Earning | (2.92) X | 28.72 X |
| Price To Book | 2.05 X | 9.51 X |
| Price To Sales | 0.52 X | 11.42 X |
| Revenue | 84.51 M | 9.43 B |
| Gross Profit | (85.66 M) | 27.38 B |
| EBITDA | (133.64 M) | 3.9 B |
| Net Income | (60.64 M) | 570.98 M |
| Cash And Equivalents | 208.35 M | 2.7 B |
| Cash Per Share | 1.92 X | 5.01 X |
| Total Debt | 88.59 M | 5.32 B |
| Debt To Equity | 1.24 % | 48.70 % |
| Current Ratio | 2.43 X | 2.16 X |
| Book Value Per Share | 0.79 X | 1.93 K |
| Cash Flow From Operations | (128.22 M) | 971.22 M |
| Short Ratio | 4.57 X | 4.00 X |
| Earnings Per Share | (27.73) X | 3.12 X |
| Price To Earnings To Growth | (0.10) X | 4.89 X |
| Target Price | 14.0 | |
| Number Of Employees | 186 | 18.84 K |
| Beta | 1.75 | -0.15 |
| Market Capitalization | 46.86 M | 19.03 B |
| Total Asset | 167.53 M | 29.47 B |
| Retained Earnings | (694.87 M) | 9.33 B |
| Working Capital | 32.11 M | 1.48 B |
Note: Disposition of 8000 shares by Rowinsky Eric K of Fortress Biotech at 4.31 subject to Rule 16b-3 [view details]
Fortress Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Fortress . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 7678.96 | |||
| Daily Balance Of Power | 0.5714 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 1.59 | |||
| Day Typical Price | 1.59 | |||
| Price Action Indicator | 0.045 | |||
| Period Momentum Indicator | 0.04 |
About Fortress Biotech Buy or Sell Advice
When is the right time to buy or sell Fortress Biotech? Buying financial instruments such as Fortress Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Fortress Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Wireless Thematic Idea Now
Wireless
Companies providing wireless technology and communication services. The Wireless theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Fortress Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.73) | Revenue Per Share 6.15 | Quarterly Revenue Growth (0.14) | Return On Assets (0.36) | Return On Equity (17.40) |
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.